These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1584832

  • 21. The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal.
    Rodríguez-Arias M, Aguilar MA, Miñarro J.
    Addict Biol; 2003 Jun; 8(2):167-72. PubMed ID: 12850775
    [Abstract] [Full Text] [Related]

  • 22. Conditioned fear exacerbates acute morphine dependence.
    Abrahamsen GC, Caldarone BJ, Stock HS, Schutz AD, Rosellini RA.
    Pharmacol Biochem Behav; 1995 Jun; 51(2-3):407-13. PubMed ID: 7667361
    [Abstract] [Full Text] [Related]

  • 23. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G, Morse AC, Liu J.
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [Abstract] [Full Text] [Related]

  • 24. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED, Kaplan CD, Dzoljic MR.
    Arch Int Pharmacodyn Ther; 1988 Dec; 294():64-70. PubMed ID: 3233054
    [Abstract] [Full Text] [Related]

  • 25. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M, Suzuki T, Sugano Y, Tsubai M, Misawa M, Ueda H, Misu Y.
    Life Sci; 1994 Dec; 54(8):PL113-8. PubMed ID: 7509021
    [Abstract] [Full Text] [Related]

  • 26. Enduring effects of morphine pellets revealed by conditioned taste aversion.
    Manning FJ, Jackson MC.
    Psychopharmacology (Berl); 1977 Mar 16; 51(3):279-83. PubMed ID: 403544
    [Abstract] [Full Text] [Related]

  • 27. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB.
    Neurosci Lett; 2010 Jan 14; 468(3):348-52. PubMed ID: 19922770
    [Abstract] [Full Text] [Related]

  • 28. Environment associated with morphine and experience of aggression modulate behaviors of postdependent mice.
    Rodríguez-Arias M, Felip CM, Aguilar MA, Miñarro J.
    Brain Res Bull; 2002 Jan 15; 57(2):157-63. PubMed ID: 11849821
    [Abstract] [Full Text] [Related]

  • 29. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W, Sato T, Nakagawasai O, Yaoita F, Silberring J, Tadano T, Tan-No K.
    Neuropeptides; 2013 Jun 15; 47(3):187-91. PubMed ID: 23290539
    [Abstract] [Full Text] [Related]

  • 30. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
    Kratzer U, Schmidt WJ.
    Neurosci Lett; 1998 Aug 07; 252(1):53-6. PubMed ID: 9756357
    [Abstract] [Full Text] [Related]

  • 31. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA, Nguyen P, Joharchi N, Sellers EM.
    Psychopharmacology (Berl); 1991 Aug 07; 105(3):322-8. PubMed ID: 1839177
    [Abstract] [Full Text] [Related]

  • 32. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F, Kayir H, Tayfun Uzbay I.
    Life Sci; 2003 Sep 19; 73(18):2363-71. PubMed ID: 12941438
    [Abstract] [Full Text] [Related]

  • 33. Characterization of withdrawal syndrome of morphine-dependent rats prepared by intermittent infusion technique.
    Koga Y, Inukai T.
    Psychopharmacology (Berl); 1981 Sep 19; 73(3):230-5. PubMed ID: 6787642
    [Abstract] [Full Text] [Related]

  • 34. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
    Li CL, Zhu N, Meng XL, Li YH, Sui N.
    J Psychopharmacol; 2013 Sep 19; 27(9):837-44. PubMed ID: 23784741
    [Abstract] [Full Text] [Related]

  • 35. Pleiotrophin modulates morphine withdrawal but has no effects on morphine-conditioned place preference.
    Gramage E, Vicente-Rodríguez M, Herradón G.
    Neurosci Lett; 2015 Sep 14; 604():75-9. PubMed ID: 26222257
    [Abstract] [Full Text] [Related]

  • 36. The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning.
    Parker LA, Cyr JA, Santi AN, Burton PD.
    Pharmacol Biochem Behav; 2002 May 14; 72(1-2):87-92. PubMed ID: 11900773
    [Abstract] [Full Text] [Related]

  • 37. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
    Dzoljic MR, Rademaker B, vd Poel-Heisterkamp AL, Ukponmwan OE, Haffmans J.
    Arch Int Pharmacodyn Ther; 1986 Oct 14; 283(2):222-8. PubMed ID: 3539055
    [Abstract] [Full Text] [Related]

  • 38. Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on "relapse" to opioid drugs.
    Shaham Y.
    Psychopharmacology (Berl); 1993 Oct 14; 111(4):477-85. PubMed ID: 7870990
    [Abstract] [Full Text] [Related]

  • 39. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
    Katsumata S, Minami M, Nakagawa T, Satoh M.
    Eur J Pharmacol; 1995 May 15; 278(2):143-50. PubMed ID: 7671998
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.